Diabetes is a common chronic disease affecting millions of people worldwide. It underlies
various complications and imposes many costs on individuals and society. Discovering early …

Background Gestational diabetes mellitus (GDM) is associated with increased risks of
disease for mother and child during pregnancy and after that. Early diagnosis of GDM would …

Objectives The exact underlying mechanism of developing diabetes-related cardiovascular
disease (CVD) among patients with type 2 diabetes (T2D) is not clear. Metabolomics can …

Background Previous research has suggested that the ELMO1 gene may play a role in the
development of diabetic kidney disease. Diabetic kidney disease (DKD) is a serious …

Background Identification of metabolomics profile in subjects with different blood pressure,
including normal blood pressure, elevated blood pressure, stage 1 hypertension, and stage 2 …

Background Evidence, albeit with conflicting results, has suggested that cardiometabolic risk
factors, including obesity, type 2 diabetes (T2D), dyslipidemia, and hypertension, are highly …

Background Amino acids (AAs) and acylcarnitines play a key role in metabolic disease and
can be used as biomarkers of various diseases such as malignancies, type 2 diabetes (T2D), …

Background: The intermediate metabolites associated with the development of atherosclerotic
cardiovascular disease (ASCVD) remain largely unknown. Thus, we conducted a large …

Aims Due to the importance of omics approaches in diabetes diagnosis, we were assumed
to study the scientific activities on omics and type 2 diabetes worldwide. Method Bibliometric …

Objectives Postmenopausal women are at increased risk of developing coronary artery disease
(CAD). Metabolomic approaches aim at discovering more helpful biomarkers of CAD to …